David Tallman
Overview
Explore the profile of David Tallman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adams E, Tallman D, Haynam M, Nekhlyudov L, Lustberg M
J Med Internet Res
. 2022 Sep;
24(9):e37757.
PMID: 36125848
Background: Internet and social media platforms offer insights into the lived experiences of survivors of cancer and their caregivers; however, the volume of narrative data available is often cumbersome for...
2.
Schrock M, Scarberry L, Stromberg B, Sears C, Torres A, Tallman D, et al.
J Cell Sci
. 2022 May;
135(12).
PMID: 35638575
Mitotic kinesin-like protein 2 (MKLP2; also known as KIF20A) is a motor protein with a well-established function in promoting cytokinesis. However, our results with siRNAs targeting MKLP2 and small-molecule inhibitors...
3.
Collier K, Asad S, Tallman D, Jenison J, Rajkovic A, Mardis E, et al.
JCO Precis Oncol
. 2021 Dec;
5.
PMID: 34849445
Purpose: To determine whether specific somatic copy-number alterations detectable in circulating tumor DNA (ctDNA) from patients with metastatic triple-negative breast cancer (mTNBC) are associated with sensitivity to platinum chemotherapy. Materials...
4.
Weber Z, Collier K, Tallman D, Forman J, Shukla S, Asad S, et al.
Genome Med
. 2021 May;
13(1):89.
PMID: 34016182
Background: Circulating tumor DNA (ctDNA) offers minimally invasive means to repeatedly interrogate tumor genomes, providing opportunities to monitor clonal dynamics induced by metastasis and therapeutic selective pressures. In metastatic cancers,...
5.
Zhang Y, Asad S, Weber Z, Tallman D, Nock W, Wyse M, et al.
BMC Cancer
. 2021 May;
21(1):568.
PMID: 34006255
Background: Triple-negative breast cancer (TNBC) is a heterogeneous disease and we have previously shown that rapid relapse of TNBC is associated with distinct sociodemographic features. We hypothesized that rapid versus...